ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Ironwood Pharmaceuticals, Inc. clinical trials

Also known as Microbia.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 45 studies whose lead sponsor is Ironwood Pharmaceuticals, Inc. or one of 2 companies grouped under it. 1 is recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 4, 2026.

Our grouping of 3 registry names, not the registry’s. See them and correct one ↓

Compare Ironwood Pharmaceuticals with Zealand Pharma and Takeda →

Pipeline: 1 program

Each counted once: 1 with a study Ironwood Pharmaceuticals, Inc. leads registered in the last two years.

  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Ironwood Pharmaceuticals, Inc.’s own registered studies; Ironwood Pharmaceuticals, Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Ironwood Pharmaceuticals, Inc.’s studies test, most open studies first — 9 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

1 of Ironwood Pharmaceuticals, Inc.’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. 1O
  13. N

Add it to your calendar (.ics) → With an account.

All 45 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now12%
  • Under way, not recruiting12%
  • Completed3680%
  • Stopped early716%

Phase

  • Phase 219
  • Phase 114
  • Phase 310
  • Phase 42

Where

  • United States39
  • Belgium5
  • United Kingdom5
  • Germany5
  • Poland4
  • Canada4

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 519
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 126

By the year each study started; 4 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Ironwood Pharmaceuticals, Inc.

  • Ironwood Pharmaceuticals, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    25 studies
  • Cyclerion Therapeutics
    Divested — left Ironwood Pharmaceuticals, Inc., Apr 1, 2019 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    11 studies →
  • VectivBio AG
    Acquired — became part of Ironwood Pharmaceuticals, Inc., Jun 29, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies →

Studies

Recruiting first, then most recently updated. Showing 45 of 45.